In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index, morning stiffness, and articular score). No side effects related to artrofoon treatment were observed throughout the treatment period in the main group. The results indicate high efficiency and good tolerability of the preparation and attest to advisability of its long-term use.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. V. Kachanova, A. R. Babaeva, E. Yu. Sherstoboev, et al., Byull. Eksp. Biol. Med., 145, No. 1, 64-67 (2008).
V. I. Mazurov and V. V. Rassokhin, Nauchn. Prakt. Revmatol., No. 5, 53-59 (2007).
E. L. Nasonov, Ter. Arkhiv, No. 5, 5-8 (2007).
Manual on Clinical Testing of New Pharmacological Agents. Ed. R. U. Khabriev et al., [in Russian], Moscow (2005).
S. V. Suchkov, A. N. Khitrov, T. E. Naumova, et al., Ter. Arkhiv, No. 12, 83-87 (2004).
F. C. Arnett, S. M. Edworthy, D. A. Bloch, et al. Arthritis Rheum., 31, No. 3, 315-324 (1988).
J. Fransen and P. L.van Riel, Clin. Exp. Immunol., 23, No. 5, Suppl. 39, S93-S99 (2005).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 125-127, September, 2009
Rights and permissions
About this article
Cite this article
Petrov, V.I., Babaeva, A.R., Cherevkova, E.V. et al. Efficiency and Safety of Long-Term Artrofoon Treatment in Rheumatoid Arthritis. Bull Exp Biol Med 148, 486–488 (2009). https://doi.org/10.1007/s10517-010-0743-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-010-0743-4